Cellvizio featured in 9news.com : World's smallest microscope finds cancer fasterSt. Anthony Hospital is the first hospital in Colorado to use the new advanced-imaging technology, called Cellvizio, with at-risk patients during standard endoscopy and colonoscopy procedures as well as the pancreatic and bile duct cancer detection procedure. Cellvizio allows physicians to view internal tissues cell-by-cell to pinpoint cancerous and pre-cancerous tissue more efficiently than current procedures. Dr. Matt Reveille says the new technology helps doctors respond once they identify dangerous tissue.
Cellvizio in the Sioux Falls Business JournalFantastic article by Sanford Hospital in the Sioux Falls Business Journal. "This can change the practice of medicine,” said Dr. Muslim Atiq, a gastroenterologist at Sanford. “The whole key is to find cancer before cancer occurs. To find it very early makes a big difference.”
Mini-Microscope Allows for Real-Time Analysis and Treatment of Gastrointestinal DiseasesCalifornia Pacific’s Interventional Endoscopy Service now uses an innovative imaging tool—real-time microscopy—to identify potentially cancerous tissue within the digestive tract. Comprised of the world’s smallest and most flexible microscope (smaller in diameter than a shoelace), confocal endomicroscopy magnifies tissue up to 1,000 times, enabling physicians to view the digestive tract at the cellular level and make treatment decisions. This tool is, the Cellvizio.
Eyewitness News: A technology that's so advanced, its space agedCellvizio featured on Eyewitness News: Doctors diagnose and treat with tiny microscope.
Winthrop-University Hospital Physician Uses Miniature Microscope to Examine Live Tissue at the Cellular Level During EndoscopyStavros Stavropoulos, MD, Director of Gastrointestinal Endoscopy and the Advanced Endoscopy Program at Winthrop-University Hospital, is using the world's smallest microscope to view internal tissues at the cellular level in real time during endoscopies.
Tiny new technology makes surgery easierCellvizio featured on ABC Action News: A new technology that's smaller than the tip of a pen is helping local doctors perform procedures in a more patient-friendly manner.
Tawam Hospital powers Endoscopy unit with groundbreaking technologies, including CellvizioTawam Hospital, in affiliation with Johns Hopkins Medicine, announced the addition of Cellvizio to its Endoscopy unit in order to help provide accurate diagnosis for cancer patients in the UAE and the region.
Cellvizio demonstrated at Marseille's AMBROISE PARÉ HospitalA French television report on the newest advances in the fight against cancer with the world's smallest microscope, the Cellvizio.
Endo-UpdateEndo-update 2013 is a two-day interventional endoscopy update course in Augsburg, Germany, with an internationally recognized faculty highlighting the latest research, skills, and technologies with simultaneous live sessions, state-of-the-art lectures, case discussions and interactive case presentations. More details to come soon !
WMIC Meeting 2013 SavannahThe World Molecular Imaging Congress is organized by the joint efforts of the “World Molecular Imaging Society – WMIS“, the “European Society for Molecular Imaging – ESMI” and the “Federation of Asian Societies for Molecular Imaging – FASMI“. The WMIC is led by the senior academic and industry professionals who have widely recognized expertise in molecular imaging. The scientific sessions held at the conference cover a broad spectrum of basic and translational sciences (pre-clinical to clinical) forming a Discovery-to-Delivery (D2D) process that helps facilitate academic and industrial partnerships. Through innovation, our goal is to optimize the D2D efforts leading to new medical and molecular imaging discoveries, greater linkages between research and market outcomes, and significant improvements in healthcare. Comme visit us and discover Cellvizio Dual Band for translational research!
CELLVIZIO DAY : TRAINING WORKSHOP AT PAOLI CALMETTES INSTITUTE - MARSEILLE, FRANCEAcquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duc and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.
Cellvizio News, May 2013FDA grants Mauna Kea Technologies 510(k) clearance to market AQ-Flex™19 miniprobe for fine needle aspiration procedures Mauna Kea Technologies announced that the U.S. Food and Drug Administration (FDA) has cleared the AQ‐Flex™ 19 miniprobe to provide real‐time optical biopsies during endoscopic ultrasound‐guided fine needle aspiration (EUSFNA) procedures in the digestive tract. This represents the sixth U.S. regulatory clearance for Mauna Kea Technologies’ Cellvizio on one of its dedicated miniprobes, which already obtained the CE mark in Europe.
MAUNA KEA TECHNOLOGIES ENTERS INTO MAJOR CELLVIZIO® DISTRIBUTION AGREEMENT WITH A LEADING JAPANESE MEDICAL DEVICE COMPANYPARIS, (June 13, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, reported that it has entered an exclusive distribution agreement in Japan with AMCO Inc. for a five-year period. This partnership further strengthens Mauna Kea Technologies’ ties with the Japanese market, and is a major step forward in the company’s efforts to obtain regulatory approval in the world’s second largest endoscopy device market after the US. The Japanese Ministry of Health, Labor, and Welfare (MHLW) requires foreign medical device companies to have a physical presence within the country or define a partnering distributor prior to approving a device for commercial sale.